{
    "eid": "2-s2.0-84979902932",
    "title": "The 10-year effectiveness of combination antiretroviral treatment in perinatally HIV-infected children participating in Thailand's National Access Program",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [],
    "authors": [
        "Linda Aurpibul"
    ],
    "citedby-count": 2,
    "ref-count": 19,
    "ref-list": [
        "Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access, 2011 Progress Report",
        "Children and AIDS, Fifth Stocktaking Report",
        "Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy",
        "Survival of HIV-infected children: A cohort study from the Asia-Pacific region",
        "Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: Implementation of a program of highly active antiretroviral therapy in a resource-poor setting",
        "In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy",
        "Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.",
        "Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children",
        "The changing epidemiology of the global paediatric HIV epidemic: Keeping track of perinatally HIV-infected adolescents",
        "Characterizing HIV manifestations and treatment outcomes of perinatally infected adolescents in Asia",
        "Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: A 5-year observational cohort study",
        "Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand",
        "Mortality and treatment outcomes of China's national pediatric antiretroviral therapy program",
        "Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy",
        "Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark",
        "Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012",
        "Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: Five-year growth and survival",
        "Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: A 10-year follow-up study",
        "Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the french perinatal cohort (EPF/ANRS CO10)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}